Paul Tudor Jones's LMAT Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 33,147 shares of LeMaitre Vascular, Inc. (LMAT) worth $3.62 M, representing 0.01% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in LMAT, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 69,202 shares. Largest reduction occurred in Q1 2026, reducing 60,275 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's LeMaitre Vascular (LMAT) Holding Value Over Time
Track share changes against reported price movement
Quarterly LeMaitre Vascular (LMAT) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -60,275 | Reduce 64.52% | 33,147 | $109.17 |
| Q4 2025 | +24,220 | Add 35.00% | 93,422 | $81.10 |
| Q3 2025 | +69,202 | New Buy | 69,202 | $87.51 |
| Q2 2025 | -37,219 | Sold Out | 0 | $0.00 |
| Q1 2025 | -1,793 | Reduce 4.60% | 37,219 | $83.90 |
| Q4 2024 | +20,597 | Add 111.85% | 39,012 | $92.14 |
| Q3 2024 | +18,415 | New Buy | 18,415 | $92.89 |
| Q2 2024 | -7,069 | Sold Out | 0 | $0.00 |
| Q1 2024 | +7,069 | New Buy | 7,069 | $66.36 |
| Q4 2023 | -7,574 | Sold Out | 0 | $0.00 |
| Q3 2023 | +2,211 | Add 41.23% | 7,574 | $54.48 |
| Q2 2023 | -1,150 | Reduce 17.66% | 5,363 | $67.28 |
| Q1 2023 | +1,414 | Add 27.73% | 6,513 | $0.05 |
| Q4 2022 | -12,056 | Reduce 70.28% | 5,099 | $0.05 |
| Q3 2022 | +3,683 | Add 27.34% | 17,155 | $50.66 |
| Q2 2022 | +13,472 | New Buy | 13,472 | $45.58 |
| Q3 2021 | -10,088 | Sold Out | 0 | $0.00 |
| Q2 2021 | -3,003 | Reduce 22.94% | 10,088 | $61.06 |
| Q1 2021 | -5,311 | Reduce 28.86% | 13,091 | $48.81 |
| Q4 2020 | +18,402 | New Buy | 18,402 | $40.48 |
| Q3 2019 | -12,051 | Sold Out | 0 | $0.00 |
| Q2 2019 | +12,051 | New Buy | 12,051 | $27.96 |
Paul Tudor Jones's LeMaitre Vascular Investment FAQs
Paul Tudor Jones first purchased LeMaitre Vascular, Inc. (LMAT) in Q2 2019, acquiring 12,051 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held LeMaitre Vascular, Inc. (LMAT) for 22 quarters since Q2 2019.
Paul Tudor Jones's largest addition to LeMaitre Vascular, Inc. (LMAT) was in Q3 2025, adding 69,202 shares worth $6.06 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 33,147 shares of LeMaitre Vascular, Inc. (LMAT), valued at approximately $3.62 M.
As of the Q1 2026 filing, LeMaitre Vascular, Inc. (LMAT) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in LeMaitre Vascular, Inc. (LMAT) was 93,422 shares, as reported at the end of Q4 2025.